David S Y Ong
Overview
Explore the profile of David S Y Ong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1731
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zwiers L, Grobbee D, Uijl A, Ong D
BMC Infect Dis
. 2024 Nov;
24(1):1327.
PMID: 39573994
Background: The use of real-world data has become increasingly popular, also in the field of infectious disease (ID), particularly since the COVID-19 pandemic emerged. While much useful data for research...
2.
Bogaard L, Tsoi K, van de Steeg B, Brandon E, Geers L, van Herwaarden M, et al.
Front Pharmacol
. 2024 Oct;
15:1412692.
PMID: 39403136
Background: Drug-drug interactions (DDIs) may influence the effectiveness and safety of medication treatment, which may require additional monitoring, dose adjustment or avoidance of certain drugs. DDIs involving P-glycoprotein (P-gp) affect...
3.
Mak W, Visser W, Koeleman J, Ong D
J Virol Methods
. 2024 May;
327:114949.
PMID: 38710307
Background: T cell immunity plays a pivotal role in mitigating the severity of coronavirus disease 2019 (COVID-19). Therefore, reliable functional T cell assays are required to evaluate severe acute respiratory...
4.
5.
Koeleman J, Mol S, Brand H, Ong D
Microorganisms
. 2024 Jan;
12(1).
PMID: 38276195
The aim of this study was to compare the diagnostic accuracy of nasal sampling using a novel anterior nasal swab (ANS) (Rhinoswab) versus combined oro-nasopharyngeal (OP/NP) sampling in COVID-19 suspected...
6.
Zwiers L, Ong D, Grobbee D
Glob Heart
. 2024 Jan;
19(1):1.
PMID: 38222096
[This corrects the article DOI: 10.5334/gh.1252.].
7.
Mak W, Visser W, van der Vliet M, Markus H, Koeleman J, Ong D
J Med Virol
. 2023 Aug;
95(8):e28989.
PMID: 37565645
Coronavirus disease-2019 (COVID-19) bivalent ancestral/Omicron messenger RNA (mRNA) booster vaccinations became available to boost and expand the immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infections. In a...
8.
Maraolo A, Ong D
Clin Microbiol Infect
. 2023 Jun;
29(9):1208-1210.
PMID: 37277093
No abstract available.
9.
Ong D, de Man P, Verhagen T, Doejaaren G, Dallinga M, Alibux E, et al.
J Med Virol
. 2023 May;
95(4):e28748.
PMID: 37185846
Airborne transmission is an important transmission route for the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological data indicate that certain SARS-CoV-2 variants, like the omicron variant, are...
10.
Faas M, Mak W, Markus H, van der Zwan E, van der Vliet M, Koeleman J, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560542
Despite previous coronavirus disease 2019 (COVID-19) vaccinations and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, SARS-CoV-2 still causes a substantial number of infections due to the waning of immunity...